PT Diagnos Laboratorium Utama Tbk (ISX:DGNS) ROCE %: 0.00% (As of . 20)


ISX:DGNS PT Diagnos Laboratorium Utama Tbk ISX:DGNS
19 GF Score
Price Rp230.00
! 1 Warning Sign
View Full Analysis

What is PT Diagnos Laboratorium Utama Tbk ROCE %?

PT Diagnos Laboratorium Utama Tbk ISX:DGNS +1.77% 19 ROCE % is 0.00% as of . 20. GuruFocus rates ISX:DGNS with a GF Score™ of 19/100. The stock has 1 warning sign investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. PT Diagnos Laboratorium Utama Tbk's annualized ROCE % for the quarter that ended in . 20 was 0.00%.


PT Diagnos Laboratorium Utama Tbk  (ISX:DGNS) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


PT Diagnos Laboratorium Utama Tbk ROCE % Related Terms


PT Diagnos Laboratorium Utama Tbk ROCE % Historical Data

* Premium members only.

The historical data trend for PT Diagnos Laboratorium Utama Tbk's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Diagnos Laboratorium Utama Tbk ROCE % Chart

PT Diagnos Laboratorium Utama Tbk Annual Data
Trend
ROCE %

PT Diagnos Laboratorium Utama Tbk Semi-Annual Data
ROCE %
ISX:DGNS
19GF Score
PT Diagnos Laboratorium Utama Tbk ISX:DGNS
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Diagnos Laboratorium Utama Tbk ROCE % Calculation

PT Diagnos Laboratorium Utama Tbk's annualized ROCE % for the fiscal year that ended in . 20 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: . 20 )  (A: . 20 )(A: . 20 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: . 20 )  (A: . 20 )(A: . 20 )
=/( ( ( - ) + ( - ) )/ )
=/( (+)/ )
=/
= %

PT Diagnos Laboratorium Utama Tbk's ROCE % of for the quarter that ended in . 20 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: . 20 )  (Q: . 20 )(Q: . 20 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: . 20 )  (Q: . 20 )(Q: . 20 )
=/( ( ( - ) + ( - ) )/ )
=/( ( + )/ )
=/
= %

(1) Note: The EBIT data used here is one times the annual (. 20) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 0.00% mean?
PT Diagnos Laboratorium Utama Tbk (ISX:DGNS) has a ROCE % of 0.00% as of . 20.
Is PT Diagnos Laboratorium Utama Tbk's ROCE % too high?
PT Diagnos Laboratorium Utama Tbk's current ROCE % is 0.00%. Overall, PT Diagnos Laboratorium Utama Tbk has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does PT Diagnos Laboratorium Utama Tbk's ROCE % compare to TMO and DHR?
PT Diagnos Laboratorium Utama Tbk's ROCE % of 0.00% can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Diagnostics & Research company?
A good ROCE % depends on the Medical Diagnostics & Research industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. PT Diagnos Laboratorium Utama Tbk's current ROCE % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Diagnos Laboratorium Utama Tbk stock overvalued right now?
PT Diagnos Laboratorium Utama Tbk (ISX:DGNS) has a current ROCE % of 0.00%. The current ROCE % is 0.00%. PT Diagnos Laboratorium Utama Tbk's overall GF Score™ is 19/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For PT Diagnos Laboratorium Utama Tbk (ISX:DGNS), the current ROCE % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PT Diagnos Laboratorium Utama Tbk Business Description

Address Jl. Cikditiro No. 11 A, B, C, Gedung Graha Anam Lantai 2, Kelurahan Gondangdia, Kecamatan Menteng, Jakarta Pusat, Jakarta, IDN, 10350
PT Diagnos Laboratorium Utama Tbk operates in the field of Health Support Services and Private Clinic Activities. It provides health support service activities managed by both the government and the private sector, such as health laboratories in the form of X-Ray Laboratories, and other diagnostic imaging centers, as well as blood testing, private clinics, pharmaceutical warehouses, eye banks, blood banks, sperm banks, organ transplant banks, and other medical support services. Its products and services include Clinical Pathology Laboratory, Anatomical Pathology Laboratory, Genomics Laboratory, Homecare Health Services, Corporate Health Services, Microbiology Laboratory, and Research Services.
19GF Score

Get the complete analysis for ISX:DGNS

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp230.00
Price